Hurlers Syndrome Recruiting Phase 4 Trials for Laronidase (DB00090)

Also known as: Hurler's Syndrome / Hurler Syndrome / Dysostosis multiplex (disorder) / Mucopolysaccharidosis, MPS-I (disorder) / MPS I H / (Mucopolysaccharidosis: (& [gargoylism]/[Hunter][Hurler]/[lipochondrodyst]/[Maroteaux-Lamy]/[Morquio-Brailsford]/[osteochondrodystrophy]/[Sanfilippo]/[Scheie]) or (dysostos multi) / Mucopolysaccharidosis, MPS-I-H (disorder) / Hurler's disease / Mucopolysaccharidosis, type 1: (& [gargoylism] or [Hurler's syndrome] or [Scheie's syndrome]) / Mucopolysaccharidosis I / Mucopolysaccharidosis type I [Ambiguous] / Mucopolysaccharidosis, type I

IndicationStatusPhase
DBCOND0043682 (Hurlers Syndrome)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00418821A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed InfantsTreatment